Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NRXP
NRXP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NRXP News
FDA to Announce Multiple Therapy Decisions in July
Jul 01 2026
NASDAQ.COM
NRx Pharmaceuticals' Subsidiary Launches Depression Treatment
Jun 26 2026
NASDAQ.COM
HOPE Therapeutics Launches Zeta-Navigated TMS Treatments
Jun 25 2026
Newsfilter
NRx Pharmaceuticals Faces Breach of Contract and Misrepresentation Lawsuit
Jun 24 2026
Newsfilter
ZETA and HOPE Announce First Patient Treatment with Zeta TMS Navigation System
Jun 23 2026
PRnewswire
ZETA and HOPE Announce First Patient Treatment with TMS Navigation System
Jun 23 2026
Newsfilter
NRx Pharmaceuticals Receives FDA Approval for NRX-101 Use
Jun 22 2026
NASDAQ.COM
NRx Pharmaceuticals Receives FDA Approval for NRX-101 Expanded Access
Jun 22 2026
Newsfilter
NRx Pharmaceuticals Presents Efficacy of IV Ketamine for Depression Treatment
Jun 05 2026
Newsfilter
NRx Pharmaceuticals Closes $22.3 Million Public Offering
Jun 04 2026
Newsfilter
Biotech Stocks Pre-Market Trading Insights
Jun 03 2026
NASDAQ.COM
NRx Pharmaceuticals Announces Pricing of Public Offering
Jun 03 2026
seekingalpha
NRx Pharmaceuticals Proposes Underwritten Public Offering
Jun 03 2026
NASDAQ.COM
NRx Pharmaceuticals Plans Underwritten Public Offering of Common Stock
Jun 02 2026
seekingalpha
EMOCARE: First Passive Monitoring Tool for Depression Launched
May 28 2026
Newsfilter
NRx Deploys AI-Powered TMS System in Florida Clinic
May 27 2026
Newsfilter
Show More News
